ArticleFrontiers in endocrinology2025
Clinical outcomes of frozen-thawed blastocysts with twice noninvasive chromosome screenings.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research Question: Does the double freeze-thaw procedure affect embryo quality or clinical outcomes for patients? Design: A retrospective study was conducted on patients undergoing noninvasive chromosome screening (NICS) from March 2018 to April 2024. Patients were divided into two groups: (1) the double freeze-thaw group, whose cryopreserved blastocysts underwent a second NICS after thawing because the first NICS test failed, and (2) the single freeze-thaw group, whose blastocysts were successfully analysed in the first NICS. The clinical outcomes included the detection success rate of NICS via the analysis of thawing culture medium and the live birth rate. Results: A total of 275 patients and 1, 443 embryos were included, with a NICS detection failure rate of 6.7% (96/1, 443). 87 were re-analysed after a second NICS using their thawed culture medium; 57.4% (50/87) of these re-tested embryos were classified as grade A or B. Fifty-two embryos were thawed and transferred in the double freeze-thaw group. Compared with the morphological grading before the first freezing, the ICM grade of two embryos decreased from A to B, and the TE grade of two embryos decreased from B to C before the second freezing. The results showed that there were still no significant differences in the clinical pregnancy rate (56.52% vs. 57.14%, adjusted p=0.785), early miscarriage rate (21.98% vs. 25.00%, adjusted p=0.528), ongoing pregnancy rate (44.10% vs. 42.86%, adjusted p=0.516), and live birth rate (42.86% vs. 42.86%, adjusted p=0.736) in single freeze-thaw group and double freeze-thaw group. Conclusions: Comparable clinical outcomes were achieved by re-applying NICS using the thawing culture medium compared to the single freeze-thaw group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.